Life Sciences Collaborations & Licensing
Foley’s Life Sciences Collaborations & Licensing attorneys work together to ensure you are fully protected when entering into collaborative and licensing agreements.
We counsel you on structuring, negotiating, and implementing collaborative and licensing transactions that may have a major, even transformative, impact on your life sciences company’s business. Our Collaborations & Licensing IP attorneys provide in-depth due diligence and tailor the process to fit your needs and the type and size of the transaction, while the corporate members structure competitive and well-researched agreements designed to help foster your growth and innovation in the life sciences sector. In addition, we also work closely with our FDA, antitrust, reimbursement, and other Foley attorneys to provide you with cohesive and complete transactional services.
Leveraging IP in Strategic Alliances
Life sciences companies are increasingly relying on strategic alliances as a means of financing research and development, validating technology, expanding product pipelines, and commercializing products. We offer a solid understanding of your patent portfolio, and emphasize the significance of IP as an essential driver in your deals. Given our breadth of experience and historic deal data, we counsel you not only on strictly legal issues, but can provide you with deal comparables and advice on the various business aspects of these transactions. We also work with you to sort through the myriad of deal structures and find the most appropriate solution, while negotiating the most favorable terms for your company.